Related Experiment Video
Updated: May 21, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis
Giovanni Cioffi1, Dana Cramariuc, Morten Dalsgaard
1Department of Cardiology, Villa Bianca Hospital, Trento, Italy. gcioffi@villabiancatrento.it
Insights
Higher left atrial systolic force (LASF) indicates a higher risk of cardiovascular events in patients with aortic valve stenosis (AS). This finding helps identify high-risk individuals for better management of AS.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Clinical Research
Background:
- Chronic pressure overload in hypertension or aortic valve stenosis (AS) is linked to a high-risk cardiovascular (CV) phenotype.
- Higher left atrial systolic force (LASF) is a recognized indicator of this high-risk CV phenotype.
Purpose of the Study:
- To evaluate the prognostic value of LASF in patients diagnosed with AS.
- To determine if LASF can predict major adverse cardiovascular events in individuals with AS.
Main Methods:
- Analysis of baseline and outcome data from 1,566 patients in the Simvastatin and Ezetimibe in AS (SEAS) study.
- LASF was calculated using Manning's method, with high LASF defined as exceeding the 95th percentile (>50 Kdynes/cm(2)).
- Primary outcome was a composite of major CV events, analyzed via multivariate Cox regression.
Main Results:
- Patients with high LASF experienced a higher rate of major CV events (49%) compared to those with normal LASF (34%) (P = 0.01).
- High LASF independently predicted an increased rate of major CV events (Hazard ratio 1.43), irrespective of aortic valve area and LV mass index.
- A risk score incorporating LASF stratified patients into distinct risk categories for CV events.
Conclusions:
- Elevated LASF provides significant additional prognostic information in patients with asymptomatic, mild-to-moderate AS.
- LASF can aid in identifying patients at higher risk for adverse cardiovascular outcomes.
Background And Aims:
In patients with chronic pressure overload due to hypertension or aortic valve stenosis (AS), higher left atrial systolic force (LASF) is associated with a high-risk cardiovascular (CV) phenotype. We tested LASF as prognostic marker in patients with AS.
Methods:
We used baseline and outcome data from 1,566 patients recruited in the Simvastatin and Ezetimibe in AS (SEAS) study evaluating the effect of placebo-controlled simvastatin and ezetimibe treatment on CV events. The primary outcome was a composite of major CV events, including CV death, aortic valve replacement, nonfatal myocardial infarction, hospitalization for unstable angina, heart failure caused by progression of AS, coronary artery bypass grafting, percutaneous coronary intervention, and nonhemorrhagic stroke. LASF was calculated by Manning's method. High LASF was defined as >95th percentile (50 Kdynes/cm(2)) of the distribution within the study population.
Results:
During 4.3 years of follow-up, a major CV event occurred in 38 of 78 patients with high LASF (49%) and in 513 of 1,488 (34%) with normal LASF (P = 0.01). In multivariate Cox regression analysis, high LASF predicted higher rate of major CV events (Hazard ratio 1.43 [95% confidence interval 1.01-2.03] independent of aortic valve area and LV mass index. A simple risk score including absence or presence of these three variables allowed risk stratification into low, intermediate, high and very high risk for major CV events during follow-up (22%, 28%, 38%, and 53%, respectively).
Conclusions:
Higher LASF provides additional prognostic information in patients with asymptomatic mild-to-moderate AS.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis III: Medical Management